General MedicationsINJECTIONGeneric

DUOCAINE

BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE

Standard Dose

EQ 0.375% (37.5MG/10ML);EQ 1% (100MG/10ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview DUOCAINE is listed in Drugs@FDA under application 021496 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 0.375% (37.5MG/10ML);EQ 1% (100MG/10ML) Sponsor AMPHASTAR PHARMS INC Submission history Latest submission status date: 2003-05-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview DUOCAINE is listed in Drugs@FDA under application 021496 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 0.375% (37.5MG/10ML);EQ 1% (100MG/10ML) Sponsor AMPHASTAR PHARMS INC Submission history Latest submission status date: 2003-05-23 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.